A detailed history of Resurgent Financial Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Resurgent Financial Advisors LLC holds 4,383 shares of BMY stock, worth $253,162. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,383
Previous 6,068 27.77%
Holding current value
$253,162
Previous $252,000 10.32%
% of portfolio
0.13%
Previous 0.15%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $66,827 - $87,198
-1,685 Reduced 27.77%
4,383 $226,000
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $244,237 - $321,543
6,068 New
6,068 $252,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $7,029 - $8,388
-145 Reduced 3.99%
3,489 $179,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $1,099 - $1,229
19 Added 0.53%
3,634 $210,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $25,738 - $28,578
404 Added 12.58%
3,615 $231,000
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $351,417 - $398,586
-5,348 Reduced 62.48%
3,211 $222,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $96,488 - $114,255
1,409 Added 19.71%
8,559 $615,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $18 - $10,911
142 Added 2.03%
7,150 $508,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $38,924 - $42,869
536 Added 8.28%
7,008 $540,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $196,182 - $235,240
3,191 Added 97.26%
6,472 $473,000
Q4 2021

May 16, 2022

BUY
$53.63 - $62.52 $175,960 - $205,128
3,281 New
3,281 $205,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Resurgent Financial Advisors LLC Portfolio

Follow Resurgent Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resurgent Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resurgent Financial Advisors LLC with notifications on news.